<DOC>
	<DOC>NCT02347319</DOC>
	<brief_summary>Purpose - To evaluate the efficacy of Biphenyl dimethyl dicarboxylate(DDB)/Garlic Oil in patients with elevated transaminase chronic liver disease.</brief_summary>
	<brief_title>To Evaluate the Efficacy of DDB/Garlic Oil in Patients With Elevated Transaminase Chronic Liver Disease</brief_title>
	<detailed_description>Biphenyl dimethyl dicarboxylate (DDB) combined with garlic oil (pennel) has been used to treat chronic liver disease. A randomized, double-blind, active- and placebo-controlled clinical trial was conducted to investigate the efficacy, safety and quality of life in chronic liver disease patients.</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Silymarin</mesh_term>
	<mesh_term>Allyl sulfide</mesh_term>
	<mesh_term>7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic acid dimethyl ester</mesh_term>
	<criteria>Patients over 20years of age Patients with more 60 ALT in screening period. To evaluate ALT and AST at least three months. Serum Transaminase abnormal(before 6months), chronic liver disease or fatty liver, liver disease medical treatment at more than 30days Women of childbearing age get her consent for contraception, pregnancy urine test result negative. ALT&gt;10UNL on screening period. Current treatment on another clinical trial Pregnancy or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>